GPS Wealth Strategies Group’s iRadimed IRMD Stock Holding History

GPS Wealth Strategies Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-150	Closed	-$10.7K	–	1061
2025 Q3	$10.7K	Hold	150	–	–	﹤0.01%	1068
2025 Q2	$8.97K	Hold	150	–	–	﹤0.01%	1064
2025 Q1	$7.87K	Hold	150	–	–	﹤0.01%	1060
2024 Q4	$8.25K	Hold	150	–	–	﹤0.01%	993
2024 Q3	$7.54K	Hold	150	–	–	﹤0.01%	1007
2024 Q2	$6.59K	Hold	150	–	–	﹤0.01%	1009
2024 Q1	$6.6K	Hold	150	–	–	﹤0.01%	942
2023 Q4	$7.12K	Hold	150	–	–	﹤0.01%	904
2023 Q3	$6.66K	Hold	150	–	–	﹤0.01%	922
2023 Q2	$7.16K	Hold	150	–	–	﹤0.01%	909
2023 Q1	$5.9K	Buy	+150	New	+$5.45K	﹤0.01%	947
2022 Q4	–	Sell	-150	Closed	-$5K	–	597
2022 Q3	$5K	Sell	150 -104	-41%	-$3.62K	﹤0.01%	889
2022 Q2	$9K	Hold	254	–	–	﹤0.01%	786
2022 Q1	$11K	Hold	254	–	–	﹤0.01%	703
2021 Q4	$12K	Hold	254	–	–	﹤0.01%	687
2021 Q3	$9K	Hold	254	–	–	﹤0.01%	736
2021 Q2	$7K	Hold	254	–	–	﹤0.01%	805
2021 Q1	$6K	Buy	+254	New	+$6.07K	﹤0.01%	746

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GPS Wealth Strategies Group's IRMD Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of iRadimed (IRMD) in Q4 2025, closing a stake of 150 shares — an estimated $10.7K sold.

GPS Wealth Strategies Group first reported a position in IRMD in Q1 2021 and held it in 18 quarters. The position peaked at $12K in Q4 2021. 217 funds tracked by Wall St. Rank hold IRMD as of Q4 2025.

GPS Wealth Strategies Group reported no remaining iRadimed position as of Q4 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 150 iRadimed shares in Q4 2025, an estimated $10.7K.
GPS Wealth Strategies Group first reported a position in iRadimed in Q1 2021 and held it in 18 quarters.
GPS Wealth Strategies Group's iRadimed position peaked at $12K in Q4 2021.
217 funds tracked by Wall St. Rank held iRadimed as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.